Cargando…
Lacking Evidence to Recommend Neoadjuvant Chemotherapy and Definitive Radiotherapy in Muscle-Invasive Bladder Cancer: In response to: Trimodality Therapy for Muscle-Invasive Bladder Cancer: Recent Advances and Unanswered Questions published by Di Maria Jiang et al. Current Oncology Reports 2020, https://doi.org/10.1007/s11912-020-0880-5
We comment on the paper of Di Maria Jiang et al. published in Current Oncology Reports 2020, 10.1007/s11912-020-0880-5. We disagree on a major recommendation of the authors because of lacking evidence. This response is considered to be important for readers of Current Oncology Reports.
Autores principales: | Böhmer, Dirk, Grün, Arne |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7817564/ https://www.ncbi.nlm.nih.gov/pubmed/33471212 http://dx.doi.org/10.1007/s11912-020-01012-8 |
Ejemplares similares
-
Trimodality Treatment for Muscle-Invasive Bladder Cancer: An Institutional Experience
por: Polineni, Praneet, et al.
Publicado: (2021) -
Single Institutional Experience of Bladder-Preserving Trimodality Treatment for Muscle-Invasive Bladder Cancer
por: Joung, Jae Young, et al.
Publicado: (2008) -
The Role of Transurethral Resection in Trimodal Therapy for Muscle-Invasive Bladder Cancer
por: Russell, Christopher M., et al.
Publicado: (2016) -
In response: “Unexpected deposits in the anesthetic circuit: a possible cause of PEEP/Pmax valve malfunction” from T. Ikeda et al. https://doi.org/10.1007/s10877-020-00562-3
por: Schüler, Hans Ulrich
Publicado: (2020) -
Outcomes for Muscle-invasive Bladder Cancer with Radical Cystectomy or Trimodal Therapy in US Veterans
por: Kumar, Abhishek, et al.
Publicado: (2021)